Q9970 HCPCS Level II code: Injection, ferric carboxymaltose, 1mg
CMS terminated Q9970: its last date of service was Dec 31, 2014. It stays here for looking up older claims; newer services need a current code.
Official description
Q9970Injection, ferric carboxymaltose, 1mg
Short description: Inj ferric carboxymaltos 1mg
HCPCS · United States
Medicare details
The indicators CMS publishes with Q9970 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Carrier judgment
- Medicare pricing
- Drugs
- Type of service
- Medical care; Lump sum purchase of DME, prosthetics, orthotics
- BETOS category
- Other drugs
- Added
- Jul 1, 2014
- Terminated after
- Dec 31, 2014
Where Q9970 sits
- 1Q codesTemporary codes
- 2Terminated Q9970Injection, ferric carboxymaltose, 1mg
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
Is HCPCS code Q9970 still valid?
No. CMS terminated Q9970; its last date of service was Dec 31, 2014. It is listed for looking up services from before then. Use a current code for newer services.
Does Medicare cover Q9970?
CMS lists Q9970’s Medicare coverage as “Carrier judgment” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside Q9970
All Q codesQ9964High osmolar contrast material, 400 or greater mg/ml iodine concentration, per mlQ9965Low osmolar contrast material, 100-199 mg/ml iodine concentration, per mlQ9966Low osmolar contrast material, 200-299 mg/ml iodine concentration, per mlQ9967Low osmolar contrast material, 300-399 mg/ml iodine concentration, per mlQ9968Injection, non-radioactive, non-contrast, visualization adjunct (e.g., methylene blue, isosulfan blue), 1 mgQ9969Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study doseQ9972Injection, epoetin beta, 1 microgram, (for esrd on dialysis)Q9973Injection, epoetin beta, 1 microgram, (non-esrd use)Q9974Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mgQ9975Injection, factor viii fc fusion protein (recombinant), per iuQ9976Injection, ferric pyrophosphate citrate solution, 0.1 mg of ironQ9977Compounded drug, not otherwise classified